FDA Issues Final Guidance on the 510(k) Third Party Review Program
US – FDA Issues Final Guidance on the 510(k) Third Party Review Program
Published in 510(k) Third Party Review Program, Premarket Notification - 510(k) and United States Food and Drug Administration - US FDA
More from Premarket Notification - 510(k)More posts in Premarket Notification - 510(k) »
- UU – Final guidance – Premarket Notification (510(k)) Submissions for Electrosurgical Devices for General Surgery
- US Final Guidance – Bone Anchors – Premarket Notification (510(k)) Submissions
- US – FDA eSTAR Pilot Program (510(k) Program Pilots)
- US FDA Final Guidance – Clinical Performance Assessment: Considerations for Computer-Assisted Detection Devices Applied to Radiology Images and Radiology Device Data – Premarket Approval (PMA) and Premarket Notification [510(k)]
- US – Medical Devices; Exemption From Premarket Notification; Class II Devices; Powered Wheeled Stretcher
More from United States Food and Drug Administration - US FDAMore posts in United States Food and Drug Administration - US FDA »
- EU – Team-NB Position Paper on Documentation Requirements for Drug Device Combination Products Falling in the Scope of Article 117 of MDR 2017/745.
- US – FDA Issues Immediately in Effect Guidance on Ventilators During COVID-19
- US – Ventilator Supply Mitigation Strategies – Letter to Health Care Providers
- US – Update on the Ethylene Oxide Sterilization Master File Pilot Program
- US – FDA Engagement to Mitigate Potential Shortage of Personal Protective Equipment (PPE)
Be First to Comment